全球寡核苷酸合成市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

寡核苷酸合成市場預計將從 2025 年的 47.2 億美元成長到 2034 年的 148.1 億美元，2026 年至 2034 年的複合年成長率為 13.54%。

受分子生物學和遺傳學研究活性化的推動，全球寡核苷酸合成市場經歷了強勁成長。寡核苷酸是合成的短鏈核苷酸，用於遺傳學研究、診斷和治療方法開發。這些分子在基因序列測定、聚合酵素鏈鎖反應(PCR) 技術和標靶藥物開發等應用中發揮著至關重要的作用。

寡核苷酸合成市場的主要驅動力包括生物技術和藥物研發的擴張。基因治療和個人化醫療領域投資的增加正在加速對高品質合成寡核苷酸的需求。研究機構和製藥公司依賴這些分子進行基因表現研究和創新治療方法的開發。

隨著基因組學和生物技術的不斷進步，寡核苷酸合成市場預計將持續成長。合成技術的改進和自動化將提高生產效率和精確度。隨著遺傳學和分子醫學領域科學研究的拓展，合成寡核苷酸的需求預計將保持強勁。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球寡核苷酸合成市場：依產品分類

• 市場分析、洞察與預測
• 寡核苷酸
• 設備/合成設備
• 試劑
• 服務

第5章 全球寡核苷酸合成市場：依應用領域分類

• 市場分析、洞察與預測
• PCR引子
• PCR檢測與試劑盒
• 定序
• DNA微陣列
• 螢光原位雜合反應（FISH）
• 反義寡核苷酸
• 其他用途

第6章：全球寡核苷酸合成市場：依最終用途分類

• 市場分析、洞察與預測
• 學術研究機構
• 診斷檢查室
• 製藥和生物技術公司

第7章 全球寡核苷酸合成市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Thermo Fisher Scientific Inc
  • Merck KGaA
  • Danaher
  • Revvity Discovery Limited
  • Agilent Technologies Inc
  • Bio-Synthesis Inc
  • Kaneka Eurogentec SA
  • LGC Biosearch Technologies
  • Biolegio
  • Twist Bioscience

The Oligonucleotide Synthesis Market size is expected to reach USD 14.81 Billion in 2034 from USD 4.72 Billion (2025) growing at a CAGR of 13.54% during 2026-2034.

The global oligonucleotide synthesis market has experienced strong growth due to increasing research in molecular biology and genetic studies. Oligonucleotides are short sequences of nucleotides that are synthesized for use in genetic research, diagnostics, and therapeutic development. These molecules play a crucial role in applications such as gene sequencing, polymerase chain reaction techniques, and targeted drug development.

Key drivers of the oligonucleotide synthesis market include the expansion of biotechnology and pharmaceutical research. Increasing investment in genetic therapies and personalized medicine has accelerated demand for high-quality synthetic oligonucleotides. Research institutions and pharmaceutical companies rely on these molecules for studying gene expression and developing innovative treatments.

Looking ahead, the oligonucleotide synthesis market is expected to grow as advances in genomics and biotechnology continue. Improvements in synthesis technologies and automation will enhance production efficiency and accuracy. As scientific research in genetics and molecular medicine expands, the demand for synthetic oligonucleotides will remain strong.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Oligonucleotides
• Equipment/Synthesizer
• Reagents
• Services

By Application

• PCR Primers
• PCR Assays and Panels
• Sequencing
• DNA Microarrays
• Fluorescence In Situ Hybridization (FISH)
• Antisense Oligonucleotides
• Other Applications

By End-use

• Academic Research Institutes
• Diagnostic Laboratories
• Pharmaceutical and Biotechnology Companies

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, Merck KGaA, Danaher, Revvity Discovery Limited, Agilent Technologies Inc, BioSynthesis Inc, Kaneka Eurogentec SA, LGC Biosearch Technologies, Biolegio, Twist Bioscience
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Oligonucleotides Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Equipment/Synthesizer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. PCR Primers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. PCR Assays and Panels Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. DNA Microarrays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Fluorescence In Situ Hybridization (FISH) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Antisense Oligonucleotides Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Academic Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Pharmaceutical and Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Application
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Application
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Application
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Application
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Application
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL OLIGONUCLEOTIDE SYNTHESIS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Thermo Fisher Scientific Inc
  • 9.2.2 Merck KGaA
  • 9.2.3 Danaher
  • 9.2.4 Revvity Discovery Limited
  • 9.2.5 Agilent Technologies Inc
  • 9.2.6 Bio-Synthesis Inc
  • 9.2.7 Kaneka Eurogentec S.A
  • 9.2.8 LGC Biosearch Technologies
  • 9.2.9 Biolegio
  • 9.2.10 Twist Bioscience